Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

Momenta Pharmaceuticals

Jump to

Johnson & Johnson, Momenta Pharma file patent infringement lawsuit against Natco, Mylan in US

Johnson & Johnson and Momenta Pharmaceuticals lawsuit alleges infringement of two old patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate injection, Natco said in a regulatory filing.
Natco Pharma at record high, jumps 8% on US court ruling

US Supreme Court justice declined a request from Teva for a stay of an appeals court ruling that would strip the company's USD 4 billion-a-year multiple sclerosis drug Copaxone of patent protection in 2014, rather than in 2015.
Natco loses patent case against Teva of anti-sclerosis drug

Natco Pharma Ltd has lost a patent litigation against Israel's Teva Pharmaceutical Industries Ltd in the US over multiple sclerosis treatment drug, Copaxone.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347